#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14178	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2158	653.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1787	1787	T	771	T,C,A	698,3,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14178	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2158	653.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1521	1521	C	788	C	733	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26190	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3620	721.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1677	1677	A	830	A	786	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26190	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3620	721.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2311	2311	C	849	C	791	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26190	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3620	721.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2385	2385	A	822	A	777	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26190	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3620	721.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2937	2937	C	789	C	741	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	528	8	blaTEM	861	206	99.51	blaTEM.l15.c4.ctg.1	210	2.1	0	.	p	.	0	A222T	NONSYN	664	666	GCC	9	11	ACC	2;2;2	A;C;C	1;1;1	.	Betalactam resistance
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	G5V	NONSYN	13	15	GGT	286	288	GTT	118;118;118	G;T;T	116;116;114	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	E12K	NONSYN	34	36	GAA	307	309	AAA	141;145;147	A;A;A	134;139;139	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	F31L	NONSYN	91	93	TTT	364	366	TTG	190;191;192	T,C;T;G,T	170,1;170;170,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	397	399	CAA	223;222;216	C;A;A	206;209;206	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	S75P	NONSYN	223	225	TCC	496	498	CCT	181;182;183	C;C;T	167;170;168	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	V87A	NONSYN	259	261	GTA	532	534	GCA	196;194;195	G;C;A,G	187;183;184,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	V130L	NONSYN	388	390	GTC	661	663	CTC	211;212;213	C;T;C	198;195;198	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	R135C	NONSYN	403	405	CGC	676	678	TGT	220;215;219	T;G;T	199;203;200	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	T137A	NONSYN	409	411	ACG	682	684	GCG	213;212;215	G;C,G;G	202;190,2;202	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	E151K	NONSYN	451	453	GAA	724	726	AAG	208;210;211	A;A;G	198;203;202	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	T152N	NONSYN	454	456	ACC	727	729	AAT	208;206;203	A;A;T	201;201;199	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	F218L	NONSYN	652	654	TTT	925	927	TTG	134;132;130	T;T;G	128;127;125	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	955	957	AGC	123;122;122	A;G;C	119;117;115	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1024	1026	CTG	111;110;110	C;T;G	105;103;104	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1030	1032	TCC	110;112;109	T;C;C	102;104;104	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1045	1047	GTG	124;124;128	G;T;G	113;110;115	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1706	folP	852	852	93.78	folP.l15.c4.ctg.1	1528	111.3	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1096	1098	GCG	158;155;156	G,A;C,T;G	144,1;139,1;144	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5486	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3396	161.1	1	SNP	p	S91F	0	.	.	271	273	TCC	583	585	TCC	175;173;175	T;C;C	162;163;165	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5486	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3396	161.1	1	SNP	p	D95G	0	.	.	283	285	GAC	595	597	GAC	178;179;179	G;A;C	173;171;174	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5486	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3396	161.1	1	SNP	p	D95N	0	.	.	283	285	GAC	595	597	GAC	178;179;179	G;A;C	173;171;174	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	1788	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1428	124.8	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	770	770	T	211	T	195	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	906	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1023	88.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5106	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3074	165.5	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1498	1500	ATC	211;209;208	A;T;C	193;192;191	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5106	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3074	165.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1651	1653	GCA	212;211;210	G;C,G;A	199;194,1;193	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5106	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3074	165.5	1	SNP	p	D86N	0	.	.	256	258	GAC	604	606	GAC	221;222;222	G;A;C,T	208;205;208,1	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5106	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3074	165.5	1	SNP	p	S87I	0	.	.	259	261	AGT	607	609	AGT	223;220;218	A;G;T	205;205;205	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5106	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3074	165.5	1	SNP	p	S87W	0	.	.	259	261	AGT	607	609	AGT	223;220;218	A;G;T	205;205;205	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5106	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3074	165.5	1	SNP	p	S87R	0	.	.	259	261	AGT	607	609	AGT	223;220;218	A;G;T	205;205;205	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5106	parC	2304	2304	99.74	parC.l6.c30.ctg.1	3074	165.5	1	SNP	p	S88P	0	.	.	262	264	TCC	610	612	TCC	218;217;218	T;C,A;C	201;201,1;204	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4534	parE	1986	1986	99.95	parE.l15.c30.ctg.1	2751	164.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1537	1539	GGC	243;241;243	G;G;C	228;227;229	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1297	1299	GCA	221;223;224	G,A;C;A	199,1;205;205	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1300	1302	ATC	224;225;226	A;T;C	206;206;209	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1312	1314	GTG	226;224;226	G;T;G	212;210;212	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1312	1314	GTG	226;224;226	G;T;G	212;210;212	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1816	1818	ACC	204;204;204	A;C;C	188;188;187	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1870	1872	GCG	208;204;205	G;C;G	185;174;178	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1870	1872	GCG	208;204;205	G;C;G	185;174;178	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1993	1995	GGT	158;157;156	G;G;T	142;141;137	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2002	2004	GGC	162;158;159	G;G;C	143;138;135	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4062	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2423	167.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2020	2022	CCG	151;152;151	C,G,T;C;G	120,3,1;121;116	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5686	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3012	187.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2404	porA	1146	1146	99.74	porA.l15.c30.ctg.1	1965	122.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	433	435	GGC	150;147;148	G;G;C	141;138;139	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2404	porA	1146	1146	99.74	porA.l15.c30.ctg.1	1965	122.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	615	615	C	169	C	160	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2914	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1456	198.9	0	.	p	.	0	R143G	NONSYN	427	429	AGA	699	701	GGA	207;207;207	G,A,C;G,A;A	193,1,1;194,1;194	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2914	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1456	198.9	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	903	903	T	226	T	208	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2914	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1456	198.9	1	SNP	p	G120K	0	.	.	358	360	GGT	630	632	GGT	221;217;215	G;G;T	208;206;205	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2914	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1456	198.9	1	SNP	p	A121N	0	.	.	361	363	GCC	633	635	GCC	212;211;211	G;C;C	199;203;202	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2914	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1456	198.9	1	SNP	p	A121D	0	.	.	361	363	GCC	633	635	GCC	212;211;211	G;C;C	199;203;202	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10560	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4717	223.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1919	1921	CAT	255;257;257	C;A;T	240;243;241	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1104	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	955	114.2	1	SNP	p	V57M	1	.	.	169	171	ATG	497	499	ATG	220;220;216	A;T;G	207;208;202	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
